Clinical Trial Update: TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection [NA]

View source ↗

Summary

A trial comparing transarterial chemoembolization (TACE) plus tegafur versus TACE alone for intrahepatic cholangiocarcinoma after curative resection; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• tegafur (tegafur)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Intrahepatic Cholangiocarcinoma | NA | Status: UNKNOWN